The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2021
Filed:
Apr. 15, 2020
Applicant:
Mochida Pharmaceutical Co., Ltd., Tokyo, JP;
Inventor:
Yuji Kawada, Tokyo, JP;
Assignee:
MOCHIDA PHARMACEUTICAL CO., LTD., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 215/44 (2006.01); C07D 213/75 (2006.01); A61K 31/4418 (2006.01); C07D 401/04 (2006.01); A61K 31/506 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); C07D 213/84 (2006.01); C07D 405/04 (2006.01); A61K 31/4433 (2006.01); C07D 405/14 (2006.01); C07D 213/81 (2006.01); C07D 413/12 (2006.01); C07D 417/04 (2006.01); A61K 45/06 (2006.01); A61P 37/00 (2006.01); A61P 1/02 (2006.01); A61P 7/00 (2006.01); A61P 13/08 (2006.01); A61P 21/00 (2006.01); A61P 25/20 (2006.01); A61P 25/28 (2006.01); A61P 31/00 (2006.01); A61P 43/00 (2006.01); A61P 1/16 (2006.01); A61P 9/00 (2006.01); A61P 9/06 (2006.01); A61P 11/06 (2006.01); A61P 37/06 (2006.01); A61P 1/18 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 11/04 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01); A61P 25/04 (2006.01); A61P 29/02 (2006.01); A61P 31/18 (2006.01); A61P 35/02 (2006.01); A61P 3/10 (2006.01); A61P 9/12 (2006.01); A61P 13/02 (2006.01); A61P 13/10 (2006.01); A61P 13/12 (2006.01); A61P 21/02 (2006.01); A61P 25/24 (2006.01); A61P 1/00 (2006.01); A61P 11/00 (2006.01); A61P 15/00 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 29/00 (2006.01); A61P 1/04 (2006.01); A61P 5/14 (2006.01); A61P 11/02 (2006.01); A61P 19/10 (2006.01); A61P 35/00 (2006.01); A61K 45/00 (2006.01); C07C 213/10 (2006.01); C07C 271/24 (2006.01);
U.S. Cl.
CPC ...
C07D 213/75 (2013.01); A61K 31/444 (2013.01); A61K 31/4418 (2013.01); A61K 31/4433 (2013.01); A61K 31/4439 (2013.01); A61K 31/506 (2013.01); A61K 45/00 (2013.01); A61K 45/06 (2013.01); A61P 1/00 (2018.01); A61P 1/02 (2018.01); A61P 1/04 (2018.01); A61P 1/16 (2018.01); A61P 1/18 (2018.01); A61P 3/04 (2018.01); A61P 3/06 (2018.01); A61P 3/10 (2018.01); A61P 5/14 (2018.01); A61P 7/00 (2018.01); A61P 9/00 (2018.01); A61P 9/06 (2018.01); A61P 9/12 (2018.01); A61P 11/00 (2018.01); A61P 11/02 (2018.01); A61P 11/04 (2018.01); A61P 11/06 (2018.01); A61P 13/02 (2018.01); A61P 13/08 (2018.01); A61P 13/10 (2018.01); A61P 13/12 (2018.01); A61P 15/00 (2018.01); A61P 17/00 (2018.01); A61P 19/02 (2018.01); A61P 19/10 (2018.01); A61P 21/00 (2018.01); A61P 21/02 (2018.01); A61P 25/00 (2018.01); A61P 25/04 (2018.01); A61P 25/08 (2018.01); A61P 25/16 (2018.01); A61P 25/20 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 29/00 (2018.01); A61P 29/02 (2018.01); A61P 31/00 (2018.01); A61P 31/18 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 37/00 (2018.01); A61P 37/06 (2018.01); A61P 43/00 (2018.01); C07C 213/10 (2013.01); C07C 215/44 (2013.01); C07C 271/24 (2013.01); C07D 213/81 (2013.01); C07D 213/84 (2013.01); C07D 401/04 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 413/12 (2013.01); C07D 417/04 (2013.01); C07B 2200/07 (2013.01); C07C 2602/10 (2017.05);
Abstract
An intermediate compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is disclosed wherein the intermediate compound is represented by formula (AM-2-RR)⋅(D-TA): in which p represents an integer of 0 to 4; Reach independently represent a halogen atom, a cyano group, a Calkyl group, a halogenated Calkyl group, a hydroxy Calkyl group, a cyanated Calkyl group, a halogenated Calkoxy group, a Calkoxy Calkyl group, a mono-/di-Calkanoyl amino group, a carboxamide group, or a Calkoxy carbonyl group; and Rand Reach independently represent a Calkyl group.
Quick Actions:
Kawada, Yuji. (2021). Intermediate compound of novel tetrahydronaphthyl urea derivative (U.S. Patent No. 10927079). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10927079
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile